HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

8th Edition of International Conference on

Nutrition and Food Sciences

March 26-28, 2026 | Singapore

Nutri 2025

Pharma (Illness) to Nutra (Wellness): A new model in healthcare industry

Speaker at International Nutrition Research Conference 2025 - Dilip Ghosh
Nutriconnect, Australia
Title : Pharma (Illness) to Nutra (Wellness): A new model in healthcare industry

Abstract:

In the past decade, the world has witnessed the explosive growth of a multi-billion-dollar industry known as functional foods/nutraceuticals/phytomedicines/Ayurceutical. Nutra(Ayur)ceuticals appear to be of benefit in both the treatment and prevention of disease. Nutra(Ayur)ceuticals often possess unique chemical actions that are unavailable in pharmaceuticals. The human has been using food bioactive and/or herbal medicine for healing purpose from the beginning of human civilization. In recent times, use of evidence-based nutraceuticals for healthcare has increased steadily all over the world although it was neglected for decades by Western societies. The current landscape sees manufacturers and consumers struggle to define the boundaries between the nutrition and pharma as recent innovation draws on disciplines spanning the two sectors. The combination therapy of pharmaceuticals and food bioactive in disease prevention and treatments is one of the most dis-cussed topics in recent time. The transition of the pharmaceutical industry from its traditional business model is ongoing and interesting to see how their next blockbuster molecule could be derived through different routes. The transition from current ‘high-risk, high-margin’ business model to ‘low cost, high volume’ nutra business model is dependent on many factors.

With nutrition and pharma taking lessons from each other, an attempt to be made in this presentation to re-define Nutra(Ayur)ceuticals /functional foods/phytopharmaceuticals as well as to summarize the application of nutraceuticals.)

Biography:

Dr. Dilip Ghosh has received his PhD in biomedical science from India & post-doc from USDA-ARS, HNRCA at Tufts University, Boston. He is an international speaker, facilitator and author and professionally associated with Nutriconnect, Australia; Adjunct- NICM HRI. He is also a Visiting Professor, Kasturba Health Society, MRC, Mumbai; Jamia Hamdard University, India & Tehran University of Medical Sciences, Iran.

Dr. Ghosh has published more than 100 papers in peer reviewed journals, numerous articles and 14 books with Academic Press & CRC Press. Two new books, “Traditional, Complementary and Integrative Medicine for Neurocognition" and "Ashwagandha: Potential Drug Candidate from Ancient Ayurvedic Remedy" to be published in September-October, 2025. Dr Ghosh is also a recipient of IASTAM­—Zandu Oration Award 2022-23. Dr Ghosh has very recently nominated as Consultant, WHO-Global Traditional Medicine Center (GTMC).

Watsapp